Moroccan pharmaceutical group Laprophan has received AMMC approval for its IPO on the Casablanca Stock Exchange, targeting up to 2.22 billion dirhams (about $228 million). The offering, the third major listing planned in 2026 after T2S Group Holding and Jet Energy, will float 37.64% of the capital, according to a prospectus published by capital market […]
